UBS Lux Equity Fund Biotech USD vs T. Rowe Price US Large Cap Growth Equity Fund A USD

UBS Lux Equity Fund Biotech USD vs T. Rowe Price US Large Cap Growth Equity Fund A USD

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    5

2. T. Rowe Price US Large Cap Growth Equity Fund A USD

  • Security

    T. Rowe Price US Large Cap Growth Equity Fund A USD

  • Fee

    1.59%

  • ISIN

    LU0174119429

  • Holdings

    9

Fund Holdings

We have information about 7 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66). In comparison with T. Rowe Price US Large Cap Growth Equity Fund A USD, we have 19 holdings where Microsoft is the largest holding (9.79), followed by Nvidia (9.77) and Apple (9.5).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and T. Rowe Price US Large Cap Growth Equity Fund A USD.

UBS Lux Equity Fund Biotech USD T. Rowe Price US Large Cap Growth Equity Fund A USD
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Microsoft Corp
USA
9.79 %
2. Moderna Inc
9.21 %
2. Nvidia Corp
USA
9.77 %
3. Gilead Sciences Inc
USA
4.66 %
3. Apple Inc
USA
9.5 %
4. BioNTech SE
4.13 %
4. Amazon.com Inc
USA
6.32 %
5. Karuna Therapeutics Inc
3.75 %
5. Alphabet Inc Class A
USA
4.72 %
- 6. Meta Platforms A
USA
4.69 %
- 7. Broadcom Inc
USA
3.93 %
- 8. Mastercard Inc
USA
3.54 %
- 9. Intuit Inc
3.24 %

The list of fund holdings was last updated on September 10, 2025.